Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD — Boston, Massachusetts

Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 6/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD has participated in 2 clinical trials.

Therapeutic areas: Ovarian Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Sponsors: Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

• Massachusetts General Hospital Translational and Clinical Research Center
• Boston VA CSP Coordinating Center
• Boston Children's Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
• Massachusetts General Hospital Site Number : 002
• Laboratories of Cognitive Neuroscience, Boston Children's Hospital
• The Brigham and Women's Hospital Department of Anesthesiology
• Tuft University Hospital
• Boston Children's Hospital /ID# 162863
• Dana Farber Cancer Institute/Children's Hospital of Boston
• Brigham and Women's Hospital
• Brigham & Woman's Hospital/Boston
• Caritus St. Elizabeth's Hospital

Sponsor Feasibility Report

Trust Score: 6/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD?

Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD has a Crixeo Trust Score of 6/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD conducted?

Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD has 2 clinical trials on record. Their work covers Ovarian Cancer, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Is Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD accredited by Crixeo Clinical Trials?

Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Attn: Vasilika Koci, PharmD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.